This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1M Romano (2008) Inflammation resolution: does the bone marrow have a say? Am J Hematol 83, 435–436.
2PC Calder (2006) Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75, 197–202.
3PC Calder (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Other Lipid Mediat 77, 327–335.
4H Seki , Y Tani & M Arita (2009) Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat 89, 126–130.
6R Medzhitov (2008) Origin and physiological roles of inflammation. Nature 454, 428–435.
7P Singer , H Shapiro , M Theilla , (2008) Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 34, 1580–1592.
8A Gil , C María Aguilera , M Gil-Campos & R Cañete (2007) Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Br J Nutr 98, Suppl. 1, S121–S126.
9S Basu (2010) Bioactive eicosanoids: Role of prostaglandin F2α and F2-isoprostanes in inflammation and oxidative stress related pathology. Mols Cells 30, 383–391.
10CN Serhan , S Yacoubian & R Yang (2008) Anti-inflammatory and pro-resolving lipid mediators. Annu Rev Pathol 3, 279.
14C Galli & PC Calder (2009) Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab 55, 123–139.
15JM Schwab & CN Serhan (2006) Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol 6, 414–420.
16R Jadad , R Moore , D Carroll , (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17, 1–12.
17KF Schulz , DG Altman & D Moher (2010) CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 1, 100–107.
18GK Pot , IA Brouwer , A Enneman , (2009) No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals. Eur J Clin Nutr 63, 1353–1359.
19M Bouwens , Rest O van de , N Dellschaft , (2009) Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90, 415–424.
20HM Yusof , E Miles & P Calder (2008) Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men. Prostaglandins Leukot Essent Fatty Acids 78, 219–228.
21R Schubert , R Kitz , C Beermann , (2007) Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults. Nutrition 23, 724–730.
22S Fujioka , K Hamazaki , M Itomura , (2006) The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects–A randomized, placebo-controlled, double-blind study. J Nutr Sci Vitaminol 52, 261–265.
24F Thies , E Miles , G Nebe-von-Caron , (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36, 1183–1193.
25DC Nieman , D Henson , SR McAnulty , (2009) N-3 Polyunsaturated Fatty Acids Do Not Alter Immune and Inflammation Measures in Endurance Athletes. Int J Sport Nutr Exerc Metab 19, 536–546.
28YT Zhao , L Shao , LL Teng , (2009) Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure. J Int Med Res 37, 1831–1841.
29HMF Tulk & LE Robinson (2009) Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome. Metabolism 58, 1709–1716.
30LM Browning , JD Krebs , CS Moore , (2007) The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9, 70–80.
31MM Engler , MB Engler & MJ Malloy (2005) Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 95, 869–871.
32T Mori , RJ Woodman , V Burke , (2003) Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 35, 772–781.
33AC Skulas-Ray , PM Kris-Etherton , WS Harris , (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 93, 243.
34RG Bowden , RL Wilson , E Deike , (2011) Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Pract 24, 508–512.
35GB Perunicic-Pekovic , ZR Rasic , SI Pljesa , (2007) Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology 12, 331–336.
36Y Freund-Levi , E Hjorth , C Lindberg , (2009) Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study. Dement Geriatr Cogn Disord 27, 481–490.
37I Vedin , T Cederholm , Y Freund Levi , (2008) Effects of docosahexaenoic acid–rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Am J Clin Nutr 87, 1616.
38VM Barbosa , Ea Miles , C Calhau , (2010) Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 14, R5.
39K Mayer , S Meyer , M Reinholz-Muhly , (2003). Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol 171, 4837.
40X Wang , W Li , N Li , (2008) w-3 Fatty Acids–Supplemented Parenteral Nutrition Decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: A Randomized and controlled study. Nutr Clin Pract Nutr Clin Pract 32, 236–241.
42DC Nieman , DA Henson , SJ Gross , (2007) Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc 39, 1561–1569.
43H Bruunsgaard , M Pedersen & BK Pedersen (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8, 131–136.
44AD Toft , M Thorn , K Ostrowski , (2000) N-3 polyunsaturated fatty acids do not affect cytokine response to strenuous exercise. J Appl Physiol 89, 2401–2406.
45LA Smith , GM Paszkiewicz , AD Hutson , (2010) Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo investigations. Immunol Res 46, 94–126.
47A Saifullah , BA Watkins , C Saha , (2007) Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients–a pilot study. Nephrol Dial Transplant. 22, 3561–3567.
48JM Martin & RD Stapleton (2010) Omega-3 fatty acids in critical illness. Nutr Rev 68, 531–541.
49G Bannenberg & CN Serhan (2010) Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim Biophys Acta 1801, 1260–1273.
51PM Kris-Etherton (2000) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
52C Nälsén , B Vessby , L Berglund , M Uusitupa , K Hermansen , G Riccardi , (2006) Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J Nutr 136, 1222–1228.